Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:BICX NYSE:CCM NASDAQ:MRAI OTCMKTS:PCHM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBICXBiocorrx$0.41$0.38$0.20▼$1.45$7.31M0.1617 shsN/ACCMConcord Medical Services$5.40+7.9%$5.73$3.80▼$10.77$23.43M-0.9421,982 shs4,874 shsMRAIMarpai$1.44-3.6%$1.34$0.40▼$1.68$23.93M4.6616,481 shs17,352 shsPCHMPharmChem$3.70-0.1%$3.77$2.95▼$3.98$17.21M0.618,447 shs11,529 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBICXBiocorrx0.00%+7.74%+2.35%+31.60%+36.47%CCMConcord Medical Services-1.63%+1.29%-8.66%-37.70%-29.93%MRAIMarpai+12.03%+11.19%+6.43%+10.37%+140.32%PCHMPharmChem0.00%+0.33%-5.08%+13.91%+23.40%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBICXBiocorrxN/AN/AN/AN/AN/AN/AN/AN/ACCMConcord Medical ServicesN/AN/AN/AN/AN/AN/AN/AN/AMRAIMarpaiN/AN/AN/AN/AN/AN/AN/AN/APCHMPharmChem1.1635 of 5 stars0.03.00.00.03.00.81.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBICXBiocorrx 0.00N/AN/AN/ACCMConcord Medical Services 0.00N/AN/AN/AMRAIMarpai 0.00N/AN/AN/APCHMPharmChem 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBICXBiocorrx$10K731.35N/AN/A($0.93) per share-0.44CCMConcord Medical Services$383.96M0.06N/AN/A$51.05 per share0.11MRAIMarpai$34.87M0.69N/AN/A($1.72) per share-0.83PCHMPharmChem$6.09M2.83N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBICXBiocorrx-$5.11M-$0.41N/A∞N/AN/AN/A-226.71%N/ACCMConcord Medical Services-$42.23MN/A0.00∞N/AN/AN/AN/AN/AMRAIMarpai-$28.75M-$1.82N/A∞N/A-85.70%N/A-100.23%8/13/2025 (Estimated)PCHMPharmChem$1.38M$0.2415.42∞N/A17.92%N/AN/AN/ALatest BICX, MRAI, CCM, and PCHM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025PCHMPharmChemN/A$0.04N/A$0.04N/A$1.56 million5/15/2025Q1 2025BICXBiocorrxN/A-$0.06N/A-$0.06N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBICXBiocorrxN/AN/AN/AN/AN/ACCMConcord Medical ServicesN/AN/AN/AN/AN/AMRAIMarpaiN/AN/AN/AN/AN/APCHMPharmChemN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBICXBiocorrxN/A0.040.03CCMConcord Medical Services1.670.460.45MRAIMarpaiN/A0.820.82PCHMPharmChemN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBICXBiocorrxN/ACCMConcord Medical ServicesN/AMRAIMarpai49.75%PCHMPharmChemN/AInsider OwnershipCompanyInsider OwnershipBICXBiocorrx21.40%CCMConcord Medical Services46.50%MRAIMarpai46.10%PCHMPharmChem17.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBICXBiocorrx317.86 million14.04 millionNot OptionableCCMConcord Medical Services9704.34 million2.32 millionNot OptionableMRAIMarpai15016.67 million5.61 millionNo DataPCHMPharmChem1704.65 million3.84 millionNot OptionableBICX, MRAI, CCM, and PCHM HeadlinesRecent News About These CompaniesShareholder Alert: The Ademi Firm investigates whether PharmChem, Inc. is obtaining a Fair Price for its Public ShareholdersJuly 21, 2025 | prnewswire.comPharmChem, Inc. Announces Acquisition by Alcohol Monitoring Systems, Inc.July 21, 2025 | prnewswire.comPharmChem, Inc. (PCHM) - Yahoo FinanceJune 26, 2025 | nz.finance.yahoo.comPharmChem, Inc. (PCHM) stock price, news, quote & history - Yahoo FinanceJune 26, 2025 | au.finance.yahoo.comPharmChem, Inc. (PCHM) Latest Press Releases & Corporate News - Yahoo FinanceApril 29, 2025 | finance.yahoo.comPharmChem (OTC:PCHM) Stock Quotes, Forecast and News SummaryFebruary 9, 2025 | benzinga.comPharmChem considers strategic alternativesFebruary 3, 2025 | msn.comPharmChem, Inc. Announces Exploration of Strategic AlternativesFebruary 3, 2025 | gurufocus.comPharmChem, Inc. Announces Exploration of Strategic AlternativesFebruary 3, 2025 | prnewswire.comCedar Creek Partners Q3 2024 ResultsOctober 24, 2024 | seekingalpha.comPharmChem, Inc. goes ex dividend tomorrowOctober 9, 2024 | msn.comCedar Creek Partners Q2 2024 ResultsJuly 31, 2024 | seekingalpha.comGetinge AB (publ) (GTN0.F)July 24, 2024 | finance.yahoo.comPharmChem, Inc. (PCHM)May 26, 2024 | finance.yahoo.comLogan Clay Products Company goes ex dividend tomorrowFebruary 8, 2024 | msn.comPharmChem, Inc. (PCHM) Stock Historical Prices & Data - Yahoo FinanceMay 19, 2023 | ca.finance.yahoo.comFilipino Food Month in QatarApril 9, 2023 | gulf-times.comG‘Boost PHL food culture, fight food insecurity’April 6, 2023 | businessmirror.com.phBPunjab Chemicals and Crop Protection Ltd (PCHM)October 7, 2022 | investing.comPCHM.PK - PharmChem, Inc. | Stock Price & Latest News | ReutersSeptember 25, 2022 | reuters.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBICX, MRAI, CCM, and PCHM Company DescriptionsBiocorrx OTCMKTS:BICX$0.41 0.00 (0.00%) As of 08/12/2025BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.Concord Medical Services NYSE:CCM$5.40 +0.40 (+7.92%) Closing price 03:53 PM EasternExtended Trading$5.40 0.00 (-0.02%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.Marpai NASDAQ:MRAI$1.44 -0.05 (-3.62%) As of 03:35 PM EasternMarpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.PharmChem OTCMKTS:PCHM$3.70 0.00 (-0.05%) As of 10:08 AM EasternPharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CAVA’s Honeymoon Ends With a 16% Stock Drop Rigetti Stock: A Long-Term Quantum Play Facing Short-Term Tests 5 Stocks Insiders Are Selling That Analysts Say Buy CoreWeave Pulls Back Into a Screaming Buy Amazon’s Bears Have Raised the White Flag—Get Excited Rocket Lab Scores Analyst Upgrades, Finalizes Geost Takeover Why BigBear.ai Stock's Dip on Earnings Can Be an Opportunity Catalysts Align: Archer Beats Estimates, Delivers Aircraft to UAE Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access